Third, western blot analysis of tissue samples from validation cohort 2 demonstrated a marked upregulation of NR4A2 protein content in ESCC tissues compared to paired NATs (Supplementary Fig. S7C, D). This evidence concerns the gene NR4A2 and esophageal squamous cell carcinoma.